Thompson Rubinstein Investment Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Thompson Rubinstein Investment Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-16,538	Closed	-$892K	–	79
2017 Q4	$892K	Sell	16,538 -100	-0.6%	-$5.47K	0.29%	59
2017 Q3	$950K	Sell	16,638 -64	-0.4%	-$3.75K	0.33%	57
2017 Q2	$1M	Sell	16,702 -162	-1%	-$9.22K	0.37%	53
2017 Q1	$918K	Buy	+16,864	New	+$831K	0.33%	57

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Thompson Rubinstein Investment Management's BIVV Position: Q1 2018 in Review

Thompson Rubinstein Investment Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 16,538 shares — an estimated $892K sold.

Thompson Rubinstein Investment Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Thompson Rubinstein Investment Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Thompson Rubinstein Investment Management sold 16,538 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $892K.
Thompson Rubinstein Investment Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Thompson Rubinstein Investment Management's Bioverativ Inc. Common Stock position peaked at $1M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Thompson Rubinstein Investment Management's 13F filing for Q1 2018, filed 6 Apr 2018.